Table 3.
Age-sex* and multivariable adjusted† odds ratios (95% CI) for hearing loss‡.
Age-sex* adjusted | Multivariable† adjusted | |||
---|---|---|---|---|
OR (95% CI) | P value | MVOR (95% CI) | P value | |
Diabetes | ||||
No diabetes | 1.0 [Ref] | 1.0 [Ref] | ||
Diabetes | 1.55 (1.29, 1.86) | < 0.001 | 1.58 (1.30, 1.93) | < 0.001 |
Prediabetes | 0.95 (0.81, 1.11) | 0.518 | 0.96 (0.81, 1.13) | 0.624 |
Blood pressure (mm Hg) | ||||
Optimal, SBP/DBP, < 120/ < 80 | 1.0 [Ref] | 1.0 [Ref] | ||
SBP, 120–139 or DBP 80–89 | 1.05 (0.90, 1.23) | 0.525 | 1.01 (0.85, 1.21) | 0.881 |
SBP 140–159 or DBP 90–99 | 1.13 (0.92, 1.38) | 0.236 | 1.11 (0.89, 1.38) | 0.365 |
SBP/DBP, ≥ 160/ ≥ 100 or medication use | 1.24 (1.03, 1.5) | 0.020 | 1.20 (0.98, 1.47) | 0.078 |
Total cholesterol (mg/dL) | ||||
Optimal, < 180 | 1.0 [Ref] | 1.0 [Ref] | ||
180–199 | 1.00 (0.82, 1.23) | 0.962 | 0.98 (0.79, 1.21) | 0.829 |
200–239 | 1.11 (0.93, 1.33) | 0.258 | 1.11 (0.91, 1.34) | 0.305 |
≥ 240 mg/dL (or statin use) | 1.14 (0.96, 1.34) | 0.128 | 1.13 (0.95, 1.35) | 0.175 |
Tobacco smoking | ||||
Never | 1.0 [Ref] | 1.0 [Ref] | ||
Current | 1.93 (1.47, 2.56) | < 0.001 | 2.02 (1.52, 2.71) | < 0.001 |
Former | 1.18 (1.03, 1.35) | 0.016 | 1.11 (0.96, 1.28) | 0.165 |
CVD risk factor burden§ | ||||
All RF optimal | 1.0 [Ref] | 1.0 [Ref] | ||
≥ 1 risk factor not optimal | 1.18 (0.89, 1.56) | 0.250 | 1.20 (0.89, 1.63) | 0.241 |
≥ 1 risk factor elevated | 1.26 (0.96, 1.65) | 0.097 | 1.31 (0.98, 1.76) | 0.069 |
1 major risk factor | 1.48 (1.14, 1.91) | 0.003 | 1.44 (1.09, 1.91) | 0.011 |
≥ 2 major RF | 2.19 (1.68, 2.86) | < 0.001 | 2.23 (1.67, 3.00) | < 0.001 |
Significant values are in italics.
DBP diastolic blood pressure, MVOR multivariable adjusted odds ratio, SBP systolic blood pressure.
*All CVD risk factors are covariates in individual risk factor models.
†Adjusted for age, sex, noise exposure, hearing aid use, and BMI. Individual risk factors are covariates in individual risk factor models.
‡Defined as PTA0.5,1,2,4 > 20 dB HL in the worse ear.
§Defined as per Table 1.